Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04978012
What this trial is testing

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Fudan University 48
Testing effectiveness (Phase 2)Ended earlyNCT01806649
What this trial is testing

BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy

Who this might be right for
Esophageal Cancer
Prince of Songkla University 5
Testing effectiveness (Phase 2)UnknownNCT02037048
What this trial is testing

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Gastric Cardia+3 more
Case Comprehensive Cancer Center 63
Large-scale testing (Phase 3)UnknownNCT01398449
What this trial is testing

Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 874
Testing effectiveness (Phase 2)UnknownNCT02740426
What this trial is testing

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

Who this might be right for
Upper Tract Urothelial CarcinomaBladder Recurrence
Peking University First Hospital 200
Not applicableLooking for participantsNCT05718726
What this trial is testing

Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)

Who this might be right for
Infection;Post Surg ProcedurePeritoneal Cancer
Hampshire Hospitals NHS Foundation Trust 300
Large-scale testing (Phase 3)Looking for participantsNCT07300514
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Who this might be right for
Maintenance Treatment of Peripheral T-cell Lymphoma
Fudan University 136
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04428151
What this trial is testing

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC 408
Large-scale testing (Phase 3)Study completedNCT01275677
What this trial is testing

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Who this might be right for
HER2/Neu PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+6 more
National Cancer Institute (NCI) 3,270
Not applicableEnrolling By InvitationNCT07829276
What this trial is testing

Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia

Who this might be right for
Malignant Tumor
Zhejiang Provincial People's Hospital 350
Post-approval studies (Phase 4)Study completedNCT00686725
What this trial is testing

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT00833625
What this trial is testing

FDG-PET-CT and Biomarkers in Esophageal Cancer

Who this might be right for
Gastrointestinal DiseaseEsophageal Cancer
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT00194935
What this trial is testing

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weill Medical College of Cornell University 32
Large-scale testing (Phase 3)Study completedNCT03802240
What this trial is testing

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 492
Not applicableUnknownNCT05452850
What this trial is testing

Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis

Who this might be right for
Amyloid CardiomyopathyCongestive Heart FailureChemotherapy Effect
Istanbul University - Cerrahpasa 30
Not applicableLooking for participantsNCT06068023
What this trial is testing

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Who this might be right for
Ampullary Adenocarcinoma
Fondazione Poliambulanza Istituto Ospedaliero 400
Post-approval studies (Phase 4)Study completedNCT04985682
What this trial is testing

ADVATE in People With Hemophilia A in India

Who this might be right for
Hemophilia A
Baxalta now part of Shire 50
Early research (Phase 1)Study completedNCT02668393
What this trial is testing

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Ended earlyNCT00048893
What this trial is testing

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
National Cancer Institute (NCI) 37
Next Page